Thursday, May 21, 2009

Clovis Oncology Gets $145M

Clovis Oncology, a new biotech startup focused on commercializing anti-cancer agents, disclosed today that it has raised $145M for the firm. The firm, which has offices in San Francisco but is based in Boulder, Colorado, said the funding came from Domain Associates, New Enterprise Associates (NEA), Versant Ventures, Aberdare Ventures, Abingworth, Frazier Healthcare Ventures, ProQuest Investments and the Company's management team. The firm was founded by former executives and founders of Pharmion, which was acquired in 2008 by Celegene for $2.9 billion. More information »